First the vaccines, now the bill. As G20 leaders called, at the weekend, for fair distribution, US pharma giants have started to announce how much their products will cost,. Meanwhile, Russia says its alternative will be cheaper.
The two American drug makers that aim to bring their vaccines to market first have now revealed their pricing strategies. Pfizer, which filed for US approval of its formula on Saturday, said earlier that a dose of its product will carry a $19.50 price tag. Moderna, thought to be close to signing a deal for a comprehensive rollout in the European Union, announced this week that it will charge between $25-37.
Continue reading https://on.rt.com/avkq